Marinus Pharmaceuticals: Q2 Earnings Snapshot
In this article:
RADNOR, Pa. (AP) — RADNOR, Pa. (AP) — Marinus Pharmaceuticals Inc. (MRNS) on Thursday reported a loss of $31.9 million in its second quarter.
On a per-share basis, the Radnor, Pennsylvania-based company said it had a loss of 61 cents.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.
The epilepsy drug developer posted revenue of $6.1 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $5.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNS at https://www.zacks.com/ap/MRNS
